Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • ASSAD: Peace Talks Will Fail And America Will 'Deal...
  • Republicans Are Ripping The White House's Dan...
  • Kuwait Is Deporting People For Minor Traffic Violations
  • NewsWatch: Stock rally’s breadth is a sign of strength,...
  • Yahoo's Board Approves $1.1 Billion Purchase Of...
  • Aston Martin hatches fun throwback speedster concept
  • Amazon's Tax Arrangements Are Nothing Short Of A...
  • Search resumes for two missing fishermen off New...
  • UK lawmakers consider probe into transparency of mining...
  • Dimon making case to keep both J.P. Morgan jobs

    FDA Panel Backs HIV Drug for Preventive USE

    Thu, 05/10/2012 - 21:26 EDT - WSJ Europe
    • PAID
    • RDF10

    An FDA advisory panel voted to back the use of an HIV drug made by Gilead Sciences to help prevent certain healthy but at-risk people from contracting the virus that causes AIDS.

    • Original article
    • Login or register to post comments
     

    Related

    • FDA Panel Backs HIV Drug for Preventive USE

      An FDA advisory panel voted to back the use of an HIV drug made by Gilead Sciences to help prevent certain healthy but at-risk people from contracting the virus that causes AIDS.

    • Doctors ‘cure’ baby born with HIV virus in Mississippi

      A baby born with the virus that causes AIDS appears to have been cured, scientists announced Sunday, describing the case of a child from Mississippi who’s now two-and-a-half-years-old and has been off medication for about a year with no signs of infection. There’s no guarantee the child will remain healthy, although sophisticated testing uncovered just traces of the virus’ genetic material still lingering. If so, it would mark only the world’s second reported cure.

    • FDA Backs Truvada to Help Prevent HIV

      FDA regulators approved Truvada, a Gilead Sciences HIV drug, for use in certain healthy people to help prevent them from contracting the virus that causes AIDS.

    • FDA panel backs first pill to block HIV infection

      A panel of federal health advisers has endorsed the first drug shown to prevent HIV infection in healthy people, clearing the way for a potentially landmark approval in the 30-year-old effort against the virus that causes AIDS.

    • FDA panel backs first pill to block HIV infection

      SILVER SPRING, Md. (AP) -- A panel of federal health advisers has endorsed the first drug shown to prevent HIV infection in healthy people, clearing the way for a potentially landmark approval in the 30-year-old effort against the virus that causes AIDS....

    • Buy Gilead Sciences: HIV And Hepatitis Drugs To Drive Growth

      By Qineqt:Gilead Sciences (GILD) has posted better than expected third quarter results on the back of strong sales of Truvada, and exceptional growth of Complera. There is upside potential for the stock, on the premise of strong growth for its newly-launched drug Stribild, and the progress with the Hepatitis C drug.

    • Gilead Sciences: Time to Take Another Look

      Bret Jensen submits:Company Overview: Gilead Sciences, Inc. (GILD), a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide.

    • Gilead: Truvada Will Pass FDA Approval

      By Qineqt:Last Friday, the Food and Drug Administration (FDA) delayed the approval of two HIV-drugs, Truvada and Quad, until September. However, Truvada has already been a treatment drug and is prescribed by some doctors as a preventive measure as well.

    • FDA Panel Considers HIV Drug for Prevention

      An FDA panel will decide whether to recommend for the first time that certain healthy but at-risk people take a drug to help prevent them from contracting the virus that causes AIDS.

    • FDA Panel Considers HIV Drug for Prevention

      An FDA panel will decide whether to recommend for the first time that certain healthy but at-risk people take a drug to help prevent them from contracting the virus that causes AIDS.

    Latest

    Yahoo's Board Approves $1.1 Billion Purchase Of Tumblr (YHOO)
    Yahoo's Board Approves $1.1 Billion Purchase...
    NBA Playoff Prediction: Here's Our Official Pick For Who Wins The Western Conference Finals
    NBA Playoff Prediction: Here's Our Official...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Aviva steps up drive for cost cuts
    • Food Demand, JM Financial, UK Startups Incubator and Sina in Our News for Today 05/17/2013
    • Budget black hole at heart of George Osborne’s finances

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1667.47 1.02% FTSE: 6723.06 0.52% Nikk.: 15138.12 0.67% DAX: 8398.00 0.33% HSI: 23082.68 0.17% FX: EUR/GBP: 1.1821 USD/EUR: 1.2833 JPY/USD: 103.165 Commodities: Gold: 1360.15

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions